Skip to main content
ZJAMP Group Co., Ltd. logo

ZJAMP Group Co., Ltd. — Investor Relations & Filings

Ticker · 002758 ISIN · CNE100002029 LEI · 3003009OKT32LB5C0T64 Shenzhen Stock Exchange Wholesale and retail trade
Filings indexed 1,563 across all filing types
Latest filing 2020-02-28 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002758

About ZJAMP Group Co., Ltd.

https://www.znjtgf.com

ZJAMP Group Co., Ltd. specializes in the comprehensive distribution and supply chain management of agricultural production materials. The company’s core operations encompass the procurement, storage, and sale of essential inputs, including chemical fertilizers such as urea, potash, and compound fertilizers, as well as pesticides, seeds, and agricultural machinery. Beyond product distribution, the organization provides integrated technical services, modern logistics solutions, and agricultural consultancy to enhance crop yields and farming efficiency. By leveraging an extensive network of distribution centers and service stations, the group facilitates the stable supply of high-quality agricultural resources. Its business model focuses on bridging the gap between manufacturers and end-users through efficient resource allocation and value-added services.

Recent filings

Filing Released Lang Actions
海通证券股份有限公司关于公司发行股份购买资产暨关联交易之独立财务顾问报告(修订稿)
Regulatory Filings
2020-02-28 Chinese
发行股份购买资产暨关联交易报告书(草案)(修订稿)
Regulatory Filings
2020-02-28 Chinese
北京中企华资产评估有限责任公司关于中国证券监督管理委员会《中国证监会行政许可项目审查一次反馈意见通知书》(192726号)所涉及问题的回复
Audit Report / Information Classification · 95% confidence The document is a detailed response from an asset appraisal company to the China Securities Regulatory Commission regarding an administrative license project review. It discusses in depth the evaluation of assets, including supplier concentration risks, financial data, asset valuation methods (such as the income approach), and detailed financial and operational analysis of the target company. The content includes extensive financial data, valuation methodology, and assessment of risks and assumptions used in the appraisal. This is characteristic of an Audit Report / Information document, which typically includes standalone audit or appraisal reports and detailed financial evaluations related to regulatory reviews. The document is lengthy (15,000 characters) and contains substantive financial and operational analysis, not merely an announcement or certification. Therefore, it is not a report publication announcement or a regulatory filing. It is not an annual or interim report, nor a management report or earnings release. The focus on asset valuation and regulatory feedback aligns best with the Audit Report / Information category (AR). Q1 2019
2020-02-28 Chinese
北京市金杜律师事务所关于公司发行股份购买资产暨关联交易之补充法律意见书(二)
Legal Proceedings Report Classification · 95% confidence The document is a legal opinion letter issued by a law firm (北京市金杜律师事务所) regarding a major asset restructuring transaction involving 浙江华通医药股份有限公司. It references Chinese securities laws, regulations on major asset restructurings, and includes detailed legal analysis on share transfer agreements, asset mortgages, insider trading investigations, and compliance with regulatory feedback. The document is titled as a "补充法律意见书(二)" (Supplementary Legal Opinion Letter (II)) and is dated February 28, 2020. It is a specialized legal opinion related to a capital transaction (issuing shares to purchase assets and related party transactions). It is not a full annual or interim financial report, nor an earnings release, call transcript, or other categories. It is a legal proceeding or compliance document related to a major transaction. Given the detailed legal analysis and the nature of the document, it fits best under the category of Legal Proceedings Report (LTR).
2020-02-28 Chinese
《中国证监会行政许可项目审查一次反馈意见通知书》之反馈意见回复的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Zhejiang Huatong Pharmaceutical Co., Ltd. regarding their response to a feedback notice from the China Securities Regulatory Commission (CSRC) related to an administrative licensing project review. It mentions the company's ongoing major asset restructuring which requires CSRC approval and the uncertainty of obtaining such approval. The document is relatively short (844 characters) and primarily serves to disclose the company's reply to regulatory feedback and the status of the asset restructuring process. It does not contain financial statements, detailed financial data, or comprehensive report content. It is an official regulatory announcement related to compliance and disclosure obligations rather than a full report or detailed financial filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2020-02-28 Chinese
立信会计师事务所(特殊普通合伙)关于公司《中国证监会行政许可项目审查一次反馈意见通知书》及附件的回复说明
Audit Report / Information Classification · 95% confidence The document is a detailed response from an accounting firm (立信会计师事务所) to the China Securities Regulatory Commission (中国证监会) regarding feedback on an administrative licensing project review. It contains extensive financial data, audit opinions, and detailed explanations about the performance commitments, financial forecasts, and verification of revenue recognition and related party transactions for Zhejiang Huatong Pharmaceutical Co., Ltd. The document includes audited financial figures, management discussion and analysis, and independent auditor and financial advisor opinions. It is not a brief announcement or a simple notification but a comprehensive report with substantive financial data and analysis related to a specific transaction and performance commitments. This aligns with the characteristics of an Audit Report / Information (AR) filing, which includes standalone audit reports, applied accounting principles, and results of internal or regulatory stress tests, excluding full annual reports. The document is not an Annual Report (10-K), Interim Report (IR), or Earnings Release (ER), nor is it a simple announcement or certification. Therefore, the most appropriate classification is AR with high confidence. 9M 2019
2020-02-28 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.